Schedule 13G ownership disclosure

SUNSHINE BIOPHARMA INC

Security class unavailable · CUSIP: 867781403

Event date: 2024-02-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,727,984
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-24-002586
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Feb 21, 2024
Reporting period
Feb 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub